[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_5025 

# __Dependence on concentration and exposure time__

## Articles mentionning the risk

* [Ayub_graphene-based_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_404.md)

## Mitigations of this risk

* [Optimizing concentration and exposure protocols](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_6898.md)

## Name of the risk

Inconsistent antiviral effectiveness

## People affected by this risk

* [Facility managers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_166.md)

## Stakeholders who can mitigate this risk

* [Facility managers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_166.md)

## Technologies linked to the risk

* [Dosing systems](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6100.md)
* [Time-controlled application methods](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6101.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

